Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3

International Journal of STD and AIDS

Volumn 22, Issue 5, 2011, Pages 263-272

  Syrjanen K ^a   Shabalova, I ^b   Naud, P ^c   Derchain, S ^d   Sarian, L ^d   Kozachenko, V ^b   Zakharchenko, S ^e   Roteli Martins, C ^f   Nerovjna, R ^g   Longatto Filho, A ^h,i   Kljukina, L ^j   Tatti, S ^k   Branovskaja, M ^l   Branca, M ^m   Grunjberga, V ⁿ   Erzen M ^o   Juschenko, A ⁿ   Hammes, L Serpa ^b   Costa, S ^p   Podistov, J ^q   Syrjanen S ^r   more..

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Russian Medical Academy of Post Diploma Education   (Russian Federation)

^c Hospital de Clinicas de Porto Alegre   (Russian Federation)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e Novgorod Municipal Dermato venereological Dispensary   (Russian Federation)

^f HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^g Novgorod Female Consultative Outpatient Hospital   (Russian Federation)

^h INSTITUTO ADOLFO LUTZ   (Brazil)

ⁱ UNIVERSITY OF MINHO   (Portugal)

^j Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^k HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^l BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^m ISTITUTO SUPERIORE DI SANITÀ   (Italy)

ⁿ Latvian Cancer Centre   (Latvia)

^o SIZE Diagnostic Center   (Slovenia)

^p UNIVERSITY OF BOLOGNA   (Italy)

^q N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^r UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

CIN; Co factors; HPV; LAMS study; Multinomial regression; NIS cohort; Progression; Prospective follow up

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCH BIOPSY; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INCIDENCE; LATIN AMERICA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; USSR; YOUNG ADULT;

EID: 79957685414     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009280     Document Type: Article

References (43)

1. Syrjänen KJ. Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol 1987;65:21-39
2. Syrjänen K, Syrjänen S. Papillomavirus Infections in Human Pathology. New York: J. Wiley & Sons, 2000: 1-615
3. Syrjänen S, Syrjänen K. The history of papillomavirus research. Cent Eur J Public Health 2008;16(Suppl):S7-S13
4. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-265
5. Castellsague X, Munoz N. Chapter 3. Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-28
6. Kataja V, Syrjänen S, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 1993;138:735-745
7. Wang SS, Zuna RE, Wentzensen N, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev 2009;18:113-120
8. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527
9. Campo S ed. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norwich, UK: Caister Academic Press, 2006: 1-424
10. Syrjänen K, Väyrynen M, Castren O, et al. Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984;60:243-248
11. Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989;11:426-439
12. Rieck G, Fiander A. The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol 2006;20:227-251
13. Almonte M, Albero G, Molano M, Carcamo C, Garcia PJ, Perez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008;26(Suppl. 11):L16-L36
14. Naud P, Matos J, Hammes L, et al. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur J Obstet Gynecol Reprod Biol 2006;124:110-118
15. Syrjänen K, Shabalova I, Petrovichev N, et al. Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections. Anticancer Res 2006;26:4729-4740
16. Syrjänen K, Shabalova I, Petrovichev N, et al. Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia. Int J STD AIDS 2008;19:16-25
17. Syrjänen K, Kulmala SM, Shabalova I, et al. Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women. Eur J Gynaecol Oncol 2008;29:114-122
18. Syrjänen K, Shabalova I, Petrovichev N, et al. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol 2007;22:723-735
19. Simen-Kapeu A, Kataja V, Yliskoski M, et al. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis 2008;40:745-751
20. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003;14:805-814
21. Syrjänen K, Naud P, Derchain S, et al. Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort. Int J STD AIDS 2008;19:251-258
22. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-328
23. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
24. Fox H, Buckley CH eds. Histopathology Reporting in Cervical Screening. NHSCSP Publications No. 10, Sheffield, 1999: 1-56
25. Fox H, Wells M eds. Haines & Taylor Obstetrical and Gynaecological Pathology, 5th edn. Edinburgh: Churchill Livinsgtone, vol. 1, 2003: 297-338
26. von Knebel-Döberitz M, Syrjänen K. Molecular markers. How to apply in practice. Gynecol Oncol 2006;103:18-20
27. Branca M, Ciotti M, Giorgi C, et al. Predicting high-risk human papillomavirus (HPV) infection, progression of cervical intraepithelial neoplasia (CIN) and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modelling. Int J Gynecol Pathol 2008;27:265-273
28. Syrjänen K, Shabalova I, Naud P, et al. Persistent high-risk human papillomavirus (HPV) infections and other endpoint markers of progressive cervical disease among women prospectively followed-up in the NIS and LAMS cohorts. Int J Gynecol Cancer 2009;19:934-942
29. Syrjänen S, Shabalova IP, Petrovichev N, et al. Human papillomavirus testing and conventional PAP smear cytology as optional screening tools of women at different risk for cervical cancer in countries of former Soviet Union. J Lower Genital Tract Dis 2002;6:97-110
30. Syrjänen K, Naud P, Derchain SM, et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS Study. Anticancer Res 2005;25:3469-380
31. Longatto-Filho A, Maeda MYS, Eržen M, et al. Conventional PAP smear and liquid-based cytology as screening tools in low-resource settings of Latin America. Experience of the Latin American Screening Study. Acta Cytol 2005;49:500-506
32. Sarian L, Derchain SM, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI) cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen 2005;12:142-149
33. Longatto-Filho A, Eržen M, Branca M, et al. Human papillomavirus (HPV) testing as an optional screening tool in low-resource settings of Latin America. Experience from the LAMS Study. Int J Gynecol Cancer 2006;16:955-962
34. Syrjänen S, Shabalova IP, Petrovichev N, et al. Sexual habits and human papillomavirus (HPV) infections among women in three new independent states of the former Soviet Union. Sex Transm Dis 2003;30:680-684
35. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-3228
36. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008;168:123-137
37. Kataja V, Syrjänen K, Syrjänen S, et al. Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol 1990;6:9-14
38. Kataja V, Syrjänen K, Syrjänen S, et al. Prognostic factors in cervical human papillomavirus (HPV) infections. Sex Transm Dis 1992;19:154-160
39. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-1226
40. Belinson S, Smith JS, Myers E, et al. Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique. Cancer Epidemiol Biomarkers Prev 2008;17:2350-2355
41. Moscicki AB, Ma Y, Wibbelsman C, et al. Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology. Obstet Gynecol 2008;112:1335-1342
42. Syrjänen K, Kataja V, Yliskoski M, Chang F, Syrjänen S, Saarikoski S. Natural history of cervical HPV lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol 1992;79:675-682
43. Östor AG. Natural history of cervical intraepithelial neoplasia - a critical review. Int J Gynecol Pathol 1993;12:186-192